Clinical Trial: Efficacy and Safety of Neostigmine Administered by Zusanli Acupoint Injection Versus Intramuscular Injection for Severe Acute Pancreatitis with Intra-abdominal Hypertension: A Multicenter Prospective Randomized Controlled Trial (China)

China, Aug. 31 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of Neostigmine Administered by Zusanli Acupoint Injection Versus Intramuscular Injection for Severe Acute Pancreatitis with Intra-abdominal Hypertension: A Multicenter Prospective Randomized Controlled Trial'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131036

Registration Time: 2026/08/27

Type: Interventional study

Primary Sponsor: The Second Affiliated Hospital of Anhui Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=323223

Published by HT Digital Content Services with permission from Health Daily Digest....